Search results
Showing results for
Researchers at the University of Oxford are starting a new study to explore the effectiveness of the anti-tumour necrosis factor (anti-TNF) drug adalimumab as a treatment for patients with COVID-19 in the community, especially care homes. The AVID-CC trial, which will be conducted by Oxford Clinical Trials Research Unit (OCTRU), will enrol up to 750 patients from community care settings throughout the UK.
David Keene
BSc (Hons) MSc DPhil MCSP MMACP David Keene - Kadoorie Professor of Trauma Rehabilitation
Srinivasa Rao Rao
MBBS, MS (res), DPhil, AFHEA Srinivasa Rao Rao - Senior Researcher in Cancer Genomics
Claudia Monaco
Claudia Monaco - Professor of Cardiovascular Inflammation
Ed Burn
Ed Burn - Senior Researcher in Epidemiology and Health Economics
Fernando Martinez Estrada
Fernando Martinez Estrada - Honorary Departmental Senior Research Associate
Kirsten Leyland
BA, MSc, DPhil Kirsten Leyland - HONORARY Postdoctoral Epidemiologist
Nasim Zargar
Nasim Zargar - Honorary Departmental Product Development Scientist and Senior Production Manager
Raashid Luqmani
DM FRCP, FRCP(E) Raashid Luqmani - Professor of Rheumatology
Alex Clarke
PhD FRCP Alex Clarke - Associate Professor and Honorary Consultant Rheumatologist, Nuffield Orthopaedic Centre
Steve Gwilym
MBBS, BSc, DPhil, FRCS (Tr & Orth) Steve Gwilym - Associate Professor & Consultant Orthopaedic Surgeon
Stephen Gerry
BSc, MSc Stephen Gerry - Senior Medical Statistician and NIHR Doctoral Research Fellow
Xavier Griffin
Xavier Griffin - Honorary Departmental Associate Professor of Trauma Surgery
James K-K Chan
MA(Cantab), DPhil(Oxon), FRCS(Plast) James K-K Chan - Honorary Departmental Clinical Lecturer